Hepatitis delta in HIV-infected individuals in Europe

AIDS

Volumn 25, Issue 16, 2011, Pages 1987-1992

  Soriano, Vincent ^a   Grint, Daniel ^b   D'Arminio Monforte, Antonella ^c   Horban, Andrzej ^d   Leen, Clifford ^e   Poveda, Eva ^a   Antunes, Francisco ^f   De Wit, Stephane ^g   Lundgren, Jens ^h,i   Rockstroh, Juergen ^j   Peters, Lars ⁱ  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c Clinica Malattie Infettive e Tropicali   (Italy)

^d SP ZOZ Wojewodzki Szpital Zakazny Centrum Diagnostyki i Terapii AIDS Warszawa   (Poland)

^e WESTERN GENERAL HOSPITAL   (United Kingdom)

^f HOSPITAL DE SANTA MARIA   (Portugal)

^g SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^h Copenhagen HIV Programme ^*  (Denmark)

ⁱ International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^j UNIVERSITY HOSPITAL BONN   (Germany)

more..

Author keywords

EuroSIDA; hepatitis delta; HIV; liver

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN G; MEMBRANE ANTIGEN; VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME IMMUNOASSAY; EUROPE; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SERUM; VIREMIA; VIRUS INTERFERENCE; VIRUS REPLICATION;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIBODIES, VIRAL; CARRIER STATE; CHRONIC DISEASE; EUROPE; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS D; HEPATITIS DELTA VIRUS; HIV SEROPOSITIVITY; HUMANS; MALE; PREVALENCE; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, VIRAL; VIRUS REPLICATION;

EID: 80054975665     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32834babb3     Document Type: Article

References (30)

1. Hughes S, Wedemeyer H, Harrison P. Hepatitis delta virus. Lancet 2011; 378:73-85.
2. Wedemeyer H, Manns M. Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat Rev Gastroenterol Hepatol 2010; 7:31-40.
3. Rizzetto M. Hepatitis D: thirty years after. J Hepatol 2009; 50:1043-1050.
4. Abbas Z, Jafri W, Raza S. Hepatitis D: scenario in the Asia-Pacific region. World J Gastroenterol 2010; 16:554-562.
5. Wedemeyer H, Heidrich B, Manns M. Hepatitis D virus infection: not a vanishing disease in Europe. Hepatology 2007; 45:1331-1332. (Pubitemid 46775802)
6. Kucirka L, Farzadegan H, Field J, Mehta S, Winters M, Glenn J, et al. Prevalence, correlates, and viral dynamics of hepatitis delta among injecting drug users. J Infect Dis 2010; 202:845-852.
7. Mocroft A, Ledergerber B, Katlama C, Kirk O, Reiss P, d'Arminio Monforte A, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 2003; 362:22-29. (Pubitemid 36835816)
8. Konopnicki D, Mocroft A, de Wit S, Antunes F, Ledergerber B, Katlama C, et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS 2005; 19:593-601. (Pubitemid 40543982)
9. Soriano V, Mocroft A, Peters L, Rockstroh J, Antunes F, Kirkby N, et al. Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe. J Antimicrob Chemother 2010; 65:548-555.
10. Le Gal F, Gordien E, Affolabi D, Hanslik T, Alloui C, Deny P, et al. Quantification of hepatitis delta virus RNA in serum by consensus real-time PCR indicates different patterns of virological response to interferon therapy in chronically infected patients. J Clin Microbiol 2005; 43:2363-2369. (Pubitemid 40656252)
11. Rockstroh J, Mocroft A, Soriano V, Tural C, Losso M, Horban A, et al. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. J Infect Dis 2005; 192:992-1002. (Pubitemid 41266795)
12. Schaper M, Rodriguez-Frias F, Jardi R, Tabernero D, Homs M, Ruiz G, et al. Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D. J Hepatol 2010; 52:658-664.
13. Morsica G, Bagaglio S, Cicconi P, Capobianchi M, Pellizzer G, Caramello P, et al. Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients. J Acquir Immune Defic Syndr 2009; 51:574-581.
14. Wedemeyer H. Re-emerging interest in hepatitis delta: new insights into the dynamic interplay between HBV and HDV. J Hepatol 2010; 52:627-629.
15. Vietheer P, Netter H, Sozzi T, Bartholomeusz A. Failure of the lamivudine-resistant rtM204I hepatitis B mutants to efficiently support hepatitis delta virus secretion. J Virol 2005; 79:6570-6573. (Pubitemid 40617265)
16. Thompson A, Nguyen T, Iser D, Ayres A, Jackson K, Littlejohn M, et al. Serum HBsAg and HBeAg titers: disease phase influences correlation with viral load and intrahepatic HBV markers. Hepatology 2010; 51:1933-1944.
17. Sonneveld M, Zoutendijk R, Janssen H. Hepatitis B surface antigen monitoring and management of chronic hepatitis B. J Viral Hepat 2011; 18:449-457.
18. Ciancio A, Rizzetto M. Peg-IFN for the treatment of hepatitis D. Nat Rev Gastroenterol Hepatol 2011; 8:304-306.
19. Farci P, Mandas A, Coiana A, Lai M, Desmet V, Van Eyken P, et al. Treatment of chronic hepatitis D with interferon - a 2a. N Engl J Med 1994; 330:88-94.
20. Wedemeyer H, Yurdaydin C, Dalekos G, Erhardt A, Çakaloglu Y, Degertekin H, et al. Peginterferon plus adefovir versus either drug alone for hepatitis delta. N Engl J Med 2011; 364:322-331.
21. Bordier B, Ohkanda J, Liu P, Lee S, Salazar F, Marion P, et al. In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus. J Clin Invest 2003; 112:407-414. (Pubitemid 38063769)
22. Sheldon J, Ramos B, Toro C, Rios P, Martinez-Alarcon J, Bottecchia M, et al. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients? Antivir Ther 2008; 13:97-102. (Pubitemid 351541678)
23. Mart́n-Carbonero L, Teixeira T, Poveda E, Plaza Z, Vispo E, Soriano V. Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues. AIDS 2011; 25:73-79.
24. Yurdaydin C, Bozkaya H, Onder F, Sentü rk H, Karaaslan H, Akdog̈an M, et al. Treatment of chronic delta hepatitis with lamivudine vs. lamivudine R interferon vs. interferon. J Viral Hepat 2008; 15:314-321. (Pubitemid 351326903)
25. Garća-Samaniego J, Soriano V, Bravo R, González-Lahoz J, Muñoz F. Viral replication in patients with multiple hepatitis virus infections. Gastroenterology 1994; 107:322-323. (Pubitemid 24195383)
26. Boyd A, Lacombe K, Miailhes P, Gozlan J, Bonnard P, Molina JM, et al. Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus. J Viral Hepat 2010; 17:65-76.
27. EASL. Clinical practice guidelines: management of chronic hepatitis. B. J Hepatol 2009; 50:227-242.
28. Soriano V, Puoti M, Peters M, Benhamou Y, Sulkowski M, Zoulim F, et al. Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel. AIDS 2008; 22:1399-1410.
29. Rockstroh J, Bhagani S, Benhamou Y, Bruno R, Mauss S, Peters L, et al. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults. HIV Med 2008; 9:82-88. (Pubitemid 351228130)
30. Castellares C, Barreiro P, Mart́n-Carbonero L, Labarga P, Vispo ME, Casado R, et al. Liver cirrhosis in HIV-infected patients: prevalence, etiology and clinical outcome. J Viral Hepat 2008; 15:165-172. (Pubitemid 351143738)